Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES



Szijgyarto, Zsolt, Flach, Koen D, Opdam, Mark, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Linn, Sabine C, Wesseling, Jelle, Ali, Simak, Bliss, Judith M, Cheang, Maggie Chon U, Zwart, Wilbert
et al (show 1 more authors) (2019) Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES. BREAST CANCER RESEARCH AND TREATMENT, 175 (1). 149 - 163.

[img] Text
Dissecting the predictive value of MAPKAKTestrogen-receptor phosphorylation axis in primary breast cancer to treatment respo.pdf - OA Published Version

Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: Breast cancer, Aromatase, Tamoxifen, Prognosis, Biomarkers
Depositing User: Symplectic Admin
Date Deposited: 06 Dec 2019 09:30
Last Modified: 29 Dec 2021 19:11
DOI: 10.1007/s10549-018-05110-x
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3065142